Patents by Inventor Kanki Komiyama

Kanki Komiyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6093402
    Abstract: Citrus amanatsudaidai peel extract, which was used as a starting materials was purified over various kinds of column chromatography (activated carbon, Amberlite IR-120B [H.sup.+ ], cellulose, Sephadex G25 and HPLC) to isolate a peptide as a white powder. This peptide is a water-soluble neutral substance and shows positive reactions to ninhydrin and sodium nitroprusside and negative reactions to anisaldehyde, phenolsulfuric acid and Dragendorff reagent. Amino acids constituting the peptide of the present invention contain aspartic acid and oxylysine in large amounts. Hair growers containing the peptide of the present invention were successful in promoting 150% proliferation of rabbit hair papilla cells when applied in a concentration of 1.4 .mu.g/ml.
    Type: Grant
    Filed: June 30, 1998
    Date of Patent: July 25, 2000
    Assignee: Yutaka Miyauchi
    Inventors: Yutaka Miyauchi, Shigeo Hasegawa, Kazuhiko Otoguro, Kanki Komiyama
  • Patent number: 5756320
    Abstract: Bioactive substances K93-0711 I-1 and I-2 having inhibitory action on IL-6 activity, are produced by culturing a microorganism belonging to the genus Streptomyces in a medium, whereby the bioactive substances K93-0711 I-1 and I-2 accumulate in the medium. These bioactive substances K93-0711 I-1 and I-2 are then isolated therefrom. The substances are effective for treatment of IL-6-involving diseases such as cancer cachexia, multiple myeloma and rheumatoid arthritis.
    Type: Grant
    Filed: January 21, 1997
    Date of Patent: May 26, 1998
    Assignee: The Kitasato Institute
    Inventors: Satoshi Omura, Kanki Komiyama, Masahiko Hayashi, Satoshi Takamatsu
  • Patent number: 4701324
    Abstract: Antibiotic 82-85-8A, or a pharmacologically acceptable non-toxic salt thereof, having the following physicochemical properties:(1) Elementary analysis: C.sub.31 H.sub.47 N.sub.8 O.sub.10 Cl (determined by high resolution mass spectrometry)(2) Molecular weight: 726.5 (determined by field desorption mass spectrometry and calculated from elementary analysis)(3) Melting point: 162.degree.-167.degree. C. (partially immersed at 160.degree. C., completely melted at 167.degree. C., no browning)(4) Specific rotation: [.alpha.].sub.D.sup.20 =-56.degree. (c=0.24, methanol)(5) Ultraviolet absorption spectrum (in methanol): shown in FIG. 1(6) Infrared absorption spectrum (KBr): shown in FIG. 2(7) Solubility:soluble: chloroform, dichloromethane, ethyl acetate, methanol, ethanol,slightly soluble: acetone,insoluble: hexane, water;(8) Color reaction:Positive: iodine, sulfuric acid, Dragendorf reactionNegative: ninhydrin, ferric chloride(9) Nature: weakly basic substance.
    Type: Grant
    Filed: November 18, 1985
    Date of Patent: October 20, 1987
    Assignee: The Kitasato Institute
    Inventors: Kanki Komiyama, Shinji Funayama, Iwao Umezawa
  • Patent number: 4612285
    Abstract: A novel antibiotic, awamycin, and its production. Awamycin is active against gram positive bacteria and exhibits growth inhibitory activity against Erhlich ascites and Sarcoma 180 cells. Some of the identifying characteristics of awamycin include a molecular weight of 744.+-.1 (mass spectrum analysis), an elementary analysis of 59.16% C, 6.48% H and 1.88% N; a melting point of 158.degree. C.; an optical rotation of [.alpha.].sub.D 24=+836.degree.. Awamycin is an acidic substance, which provides an orange colored powder, and is poorly soluble in water.
    Type: Grant
    Filed: October 25, 1983
    Date of Patent: September 16, 1986
    Assignee: Kitasato Institute
    Inventors: Iwao Umezawa, Kanki Komiyama
  • Patent number: 4550021
    Abstract: Antibiotic 81-484 of the following physico-chemical properties:(1) elementary analysis: C.sub.33 H.sub.48 O.sub.7 (high resolution mass spectrum);(2) molecular weight: 556 [Field desorption (FD) mass spectrum];(3) melting point: not clear (oily at 10.degree.-100.degree. C.);(4) specific rotation: [.alpha.].sub.D.sup.20 =-151.degree. (c=0.1, methanol);(5) ultraviolet absorption spectrum: shown in FIG. 1 (in methanol);(6) infrared absorption spectrum: shown in FIG. 2 (KBr tablet);(7) solubility: insoluble in hexane and water, soluble in diethyl ether, methanol, ethanol, dichloromethane, chloroform, ethyl acetate, butyl acetate, acetone and benzene;(8) nuclear magnetic resonance spectrum: shown in FIG. 3 (CDCl.sub.3, TMS);(9) nature: acidic substance;(10) color reaction:negative for ninhydrin, anthrone-H.sub.2 SO.sub.
    Type: Grant
    Filed: June 5, 1984
    Date of Patent: October 29, 1985
    Assignee: The Kitasato Institute
    Inventors: Iwao Umezawa, Kanki Komiyama
  • Patent number: 4533548
    Abstract: A new acidic polysaccharide is isolated from a culture of cells of the algae Chlorella pyrenoidosa. The process for producing this polysaccharide is also disclosed. This substance exhibits antitumor activity and antiviral activity and induces the production of interferon.
    Type: Grant
    Filed: November 15, 1982
    Date of Patent: August 6, 1985
    Assignee: Kitasato Institute
    Inventors: Iwao Umezawa, Kanki Komiyama
  • Patent number: 4529542
    Abstract: A novel proteinous substance KUP-PC, which is produced by culturing proteinous substance KUD-PC producing organisms belonging to the genus Streptosporangium. KUD-PC increases the antitumor activity of the anti-tumor substance, sporamycin.
    Type: Grant
    Filed: June 21, 1983
    Date of Patent: July 16, 1985
    Assignee: The Kitasato Institute
    Inventors: Iwao Umezawa, Kanki Komiyama
  • Patent number: 4512976
    Abstract: This invention relates to the antibiotic stubomycin and process for producing same by culturing streptomyces sp KG - 2245 FERM-P No.
    Type: Grant
    Filed: September 25, 1981
    Date of Patent: April 23, 1985
    Assignee: The Kitasato Institute
    Inventors: Iwao Umezawa, Kanki Komiyama, Hideo Takeshima
  • Patent number: 4147774
    Abstract: A novel antibiotic sporamycin has both anti-transplanted tumor and antibacterial activity and is produced by culturing a microorganism of the genus Streptosporangium, particularly Streptosporangium pseudovulgare PO-357 FERM-P No. 3571, ATCC No. 31308.
    Type: Grant
    Filed: July 11, 1977
    Date of Patent: April 3, 1979
    Assignee: The Kitasato Institute
    Inventors: Iwao Umezawa, Kanki Komiyama, Hideo Takeshima
  • Patent number: 3995028
    Abstract: The present invention relates to a new antibiotic designated as OS-3256-B. OS-3256-B exhibits excellent inhibitory activities against animal tumors such as leukemia L-1210, Sarcoma-180 and Hela cells and gram-positive bacteria and is classified into the diazocompounds group. However, chromatographic analysis, Rf value and other experimental data reveal that OS-3256-B is a new compound of the type of azaamino acid derivatives. The present invention also provides a process for producing OS-3256-B by fermentation, in which OS-3256-B is produced by culturing a microorganism belonging to Streptomyces candidus var. azaticus in a culture medium conventionally used for culturing Streptomyces strain microorganisms.
    Type: Grant
    Filed: August 21, 1975
    Date of Patent: November 30, 1976
    Assignee: The Kitasato Institute
    Inventors: Satoshi Omura, Iwao Umezawa, Keiki Satoh, Juichi Awaya, Kanki Komiyama, Ruiko Oiwa